CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy [Phase 2]
Summary
Phase 2 trial evaluating anti-EGFR therapy with IMRT concurrent chemoradiotherapy in locally advanced oropharyngeal carcinoma resistant to induction chemotherap…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fudan University | Conditions: Oropharyngeal Carcinoma | Phase 2 | Status: UNKNOWN